FLGT Q1 2019 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q1 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$5M+15.4% YoY

Gross Profit

$2M44.7% margin

Operating Income

-$2M-33.9% margin

Net Income

-$2M-35.5% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-5.4%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$921,000

Stock-Based Comp.

$583,000

Balance Sheet

Total Assets

$56M

Total Liabilities

$6M

Stockholders' Equity

$50M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+15.4%
Gross Profit	$2M	$2M	+27.7%
Operating Income	-$2M	-$2M	+16.9%
Net Income	-$2M	-$2M	+0.1%

Geographic Segments

UNITED STATES

$4M67%

Other Countries

$1M23%

CANADA

$538,00010%